Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update

Combined antithrombotic regimens for atrial fibrillation (AF) patients with coronary artery disease, particularly for those who have acute coronary syndrome (ACS) and/or are undergoing percutaneous coronary intervention (PCI), presents a great challenge in the real-world clinical scenario. Conventio...

Full description

Bibliographic Details
Main Authors: Shujuan Zhao, Xuejiao Hong, Haixia Cai, Mingzhou Liu, Bing Li, Peizhi Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atrial fibrillation
acute coronary syndrome
antithrombotic therapy
non-vitamin K antagonist oral anticoagulants
vitamin K antagonist
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.660986/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.660986/full

Similar Items